日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

阿哌沙班 5 mg 和 2.5 mg 每日两次与华法林用于非瓣膜性房颤患者卒中预防的比较：采用倾向评分匹配法评估其疗效和安全性

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0191722
Li, Xiaoyan; Keshishian, Allison; Hamilton, Melissa; Horblyuk, Ruslan; Gupta, Kiran; Luo, Xuemei; Mardekian, Jack; Friend, Keith; Nadkarni, Anagha; Pan, Xianying; Lip, Gregory Y H; Deitelzweig, Steve
发表日期：2018
文献求助 收藏

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

比较非维生素K拮抗剂口服抗凝剂阿哌沙班、达比加群和利伐沙班在静脉血栓栓塞症的长期治疗和预防中的疗效：系统评价和网络荟萃分析

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0160064
Cohen, A T; Hamilton, M; Bird, A; Mitchell, S A; Li, S; Horblyuk, R; Batson, S
心血管
发表日期：2016
文献求助 收藏

Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography

异常胶片和数字筛查乳腺X线摄影后的诊断成像和活检流程

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-013-2466-5
Hubbard, Rebecca A; Zhu, Weiwei; Horblyuk, Ruslan; Karliner, Leah; Sprague, Brian L; Henderson, Louise; Lee, David; Onega, Tracy; Buist, Diana S M; Sweet, Alison
发表日期：2013
文献求助 收藏